Published in Thorax on September 13, 2011
Risk-adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery. Int J Qual Health Care (2003) 6.23
No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57
Miss, Mister, Doctor: how we are titled is of little consequence. J R Soc Med (2006) 3.52
Evaluation and stages of surgical innovations. Lancet (2009) 3.04
Booked inpatient admissions and hospital capacity: mathematical modelling study. BMJ (2002) 2.96
Patient's and doctors' delays in the diagnosis of chest tumors. Lung Cancer (2002) 2.90
Challenges in evaluating surgical innovation. Lancet (2009) 2.86
Manufacturing and placing a bespoke support for the Marfan aortic root: description of the method and technical results and status at one year for the first ten patients. Interact Cardiovasc Thorac Surg (2009) 2.72
Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ (2010) 2.64
Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart (2010) 2.10
Surgical resection of lung cancer England: more operations but no trials to test their effectiveness. Thorax (2012) 2.06
Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results. J Clin Oncol (2013) 1.91
The Tailor of Gloucester: a jacket for the Marfan's aorta. Lancet (2004) 1.91
Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group. J Clin Oncol (2005) 1.90
Video assisted thoracic surgery for treatment of pneumothorax and lung resections: systematic review of randomised clinical trials. BMJ (2004) 1.83
Providing feedback to hospital doctors about prescribing errors; a pilot study. Pharm World Sci (2007) 1.82
Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. J Thorac Cardiovasc Surg (2004) 1.79
A plea for consistency in the reporting of surgical series illustrated with an analysis of 51 follow-up reports of pulmonary metastasectomy in colorectal carcinoma. J Thorac Oncol (2010) 1.66
How many births in sub-Saharan Africa and South Asia will not be attended by a skilled birth attendant between 2011 and 2015? BMC Pregnancy Childbirth (2012) 1.65
Is talc pleurodesis safe for young patients following primary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg (2006) 1.61
Monitoring risk-adjusted outcomes in congenital heart surgery: does the appropriateness of a risk model change with time? Ann Thorac Surg (2009) 1.60
A prospective randomized controlled study to assess the effectiveness of CoSeal® to seal air leaks in lung surgery. Eur J Cardiothorac Surg (2011) 1.60
Slow-growing lung cancer as an emerging entity: from screening to clinical management. Eur Respir J (2013) 1.59
Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thorac Oncol (2008) 1.58
Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax (2010) 1.53
A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the Society of Thoracic Surgeons (STS). Interact Cardiovasc Thorac Surg (2011) 1.50
The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg (2006) 1.49
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg (2004) 1.48
The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg (2010) 1.47
Prognosis after heart transplantation: transplants alone cannot be the solution for end stage heart failure. BMJ (2003) 1.41
External aortic root support: a histological and mechanical study in sheep. Interact Cardiovasc Thorac Surg (2013) 1.35
The European Thoracic Surgery Database project: modelling the risk of in-hospital death following lung resection. Eur J Cardiothorac Surg (2005) 1.35
Ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg (2007) 1.34
Levels of acute health service use among cancer survivors in the United Kingdom. Eur J Cancer (2011) 1.32
Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med (2010) 1.24
Variation in use of video assisted thoracic surgery in the United Kingdom. BMJ (2004) 1.22
Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol (2002) 1.20
MARS: a sense of perspective and an inconvenient truth. J Thorac Oncol (2013) 1.18
Analytical methods for calculating the capacity required to operate an effective booked admissions policy for elective inpatient services. Health Care Manag Sci (2003) 1.18
Assessment of whether in-hospital mortality for lobectomy is a useful standard for the quality of lung cancer surgery: retrospective study. BMJ (2003) 1.18
A method for early evaluation of a recently introduced technology by deriving a comparative group from existing clinical data: a case study in external support of the Marfan aortic root. BMJ Open (2012) 1.17
Bullous disease of the lung and cannabis smoking: insufficient evidence for a causative link. J R Soc Med (2006) 1.15
Real time monitoring of risk-adjusted paediatric cardiac surgery outcomes using variable life-adjusted display: implementation in three UK centres. Heart (2013) 1.15
A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits. Lung Cancer (2002) 1.14
IMA Health 2007. Health Care Manag Sci (2008) 1.12
External aortic root support for Marfan syndrome: early clinical results in the first 20 recipients with a bespoke implant. J R Soc Med (2010) 1.10
GRIST: Growing Recruitment in Interventional and Surgical Trials. J R Soc Med (2012) 1.10
Development of a diagnosis- and procedure-based risk model for 30-day outcome after pediatric cardiac surgery. J Thorac Cardiovasc Surg (2012) 1.09
Mesothelin and osteopontin. Eur Respir J (2013) 1.08
Cryotherapy for Lung Metastases: A Justifiable Procedure? J Thorac Oncol (2015) 1.08
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg (2006) 1.08
Delivering stepped care: an analysis of implementation in routine practice. Implement Sci (2012) 1.04
A technical note concerning non-adherence to drug therapy: exact expressions for the mean and variance of drug concentration. Health Care Manag Sci (2008) 1.04
Surgical management of aortic root disease in Marfan syndrome and other congenital disorders associated with aortic root aneurysms. Heart (2014) 1.03
Mortality in adult cardiac surgery. BMJ (2005) 1.03
Implantation of an individually computer-designed and manufactured external support for the Marfan aortic root. Multimed Man Cardiothorac Surg (2013) 1.01
Interpreting data from surgical follow-up studies: the role of modeling. J Thorac Oncol (2010) 1.01
Pulmonary metastasectomy: are observational studies sufficient evidence for effectiveness? Ann Thorac Surg (2013) 0.99
Surgical research revisited: clinical trials in the cardiothoracic surgical literature. Eur J Cardiothorac Surg (2004) 0.99
Mesothelioma: benefit from surgical resection is questionable. J Thorac Oncol (2007) 0.98
Radical surgery for mesothelioma. BMJ (2004) 0.98
Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open (2012) 0.97
The evolution of aortic root surgery for Marfan syndrome. Interact Cardiovasc Thorac Surg (2010) 0.97
Pulmonary metastasectomy: where is the evidence? J Thorac Oncol (2015) 0.97
When professional opinion is not enough. BMJ (2007) 0.96
FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients. Lung Cancer (2006) 0.95
Atenolol versus Losartan in Marfan's Syndrome. N Engl J Med (2015) 0.92
Randomized controlled trial of pulmonary metastasectomy in colorectal cancer: PulMiCC International is open in Italy. Oncologist (2013) 0.91
Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma. PLoS One (2013) 0.90
Modelling to estimate future trends in cancer prevalence. Health Care Manag Sci (2011) 0.90
The evidence on which to base practice: Different tools for different times. Eur J Cardiothorac Surg (2006) 0.90
Lung metastasectomy in colorectal cancer: is this surgery effective in prolonging life? Respirology (2010) 0.89
The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery. J Clin Epidemiol (2012) 0.89
Recursive partitioning-based preoperative risk stratification for atrial fibrillation after coronary artery bypass surgery. Am Heart J (2006) 0.89
Bone or pleura? Primary pleural osteosarcoma. J Thorac Cardiovasc Surg (2007) 0.88
Use of diagnostic information submitted to the United Kingdom Central Cardiac Audit Database: development of categorisation and allocation algorithms. Cardiol Young (2012) 0.88
A systematic review of lung-sparing extirpative surgery for pleural mesothelioma. J R Soc Med (2011) 0.87
Certified causes of death in patients with mesothelioma in South East England. BMC Cancer (2009) 0.87
Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease. Respir Res (2010) 0.87
Aortic root surgery in Marfan syndrome. Heart (2011) 0.86
Seeking consensus by formal methods: a health warning. J R Soc Med (2007) 0.86
Using non-steroidal anti-inflammatory drugs (NSAIDs) following pleurodesis. Interact Cardiovasc Thorac Surg (2006) 0.86
Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value. Respir Med (2004) 0.85
Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma. Eur J Cardiothorac Surg (2010) 0.85
Appropriateness of VATS and bedside thoracostomy talc pleurodesis as judged by a panel using the RAND/UCLA appropriateness method (RAM). Interact Cardiovasc Thorac Surg (2006) 0.84